Apollomics, Inc. announced that as a result of the updated strategic focus, and aligned with the Company?s resource needs going forward, Sanjeev Redkar, Ph.D., Company co-founder and President, and Peony Yu, M.D., Chief Medical Officer, are expected to transition to consulting roles in August.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.225 USD | +11.39% |
|
+21.83% | -75.71% |
07-16 | Apollomics Gets 180-Day Extension to Meet Nasdaq Listing Requirement | MT |
07-03 | Apollomics, Inc. Announces Leadership Team Changes | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-75.71% | 22.17M | |
+17.94% | 126B | |
+22.82% | 118B | |
+23.26% | 27.87B | |
-18.59% | 20.95B | |
-15.13% | 16.92B | |
-15.69% | 16.18B | |
+9.64% | 14.84B | |
-46.10% | 14.79B | |
+52.31% | 14.08B |
- Stock Market
- Equities
- APLM Stock
- News Apollomics, Inc.
- Apollomics, Inc. Announces Leadership Team Changes